TreeWAS – Variant ID: rs12098973

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z12.1 Special screening examination for neoplasm of intestinal tract	0.000	0.749	0.251
Z12 Special screening examination for neoplasms	0.000	0.769	0.231
Z12.0 Special screening examination for neoplasm of stomach	0.000	0.784	0.216
Z12.3 Special screening examination for neoplasm of breast	0.000	0.788	0.212
Z12.8 Special screening examination for neoplasm of other sites	0.000	0.798	0.201
Z12.6 Special screening examination for neoplasm of bladder	0.000	0.828	0.172
Z12.9 Special screening examination for neoplasm, unspecified	0.000	0.841	0.158
Z12.5 Special screening examination for neoplasm of prostate	0.000	0.848	0.152
Z12.4 Special screening examination for neoplasm of cervix	0.000	0.856	0.143
Z12.2 Special screening examination for neoplasm of respiratory organs	0.000	0.860	0.139
N73.6 Female pelvic peritoneal adhesions	0.000	0.979	0.021
I50.0 Congestive heart failure	0.021	0.979	0.000
I50 Heart failure	0.019	0.981	0.000
I50.9 Heart failure, unspecified	0.018	0.982	0.000
I50.1 Left ventricular failure	0.016	0.984	0.000
D50.8 Other iron deficiency anaemias	0.000	0.988	0.012
Y60.0 During surgical operation	0.000	0.990	0.010
K91.4 Colostomy and enterostomy malfunction	0.000	0.990	0.009
N87.1 Moderate cervical dysplasia	0.007	0.993	0.000
I42.9 Cardiomyopathy, unspecified	0.007	0.993	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.007	0.993	0.000
M25.50 Pain in joint (Multiple sites)	0.000	0.994	0.006
Y52.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
I42 Cardiomyopathy	0.006	0.994	0.000
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.005	0.995	0.000
N73 Other female pelvic inflammatory diseases	0.000	0.995	0.005
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.000	0.995	0.005
I30-I52 Other forms of heart disease	0.005	0.995	0.000
I34 Nonrheumatic mitral valve disorders	0.005	0.995	0.000
I34.1 Mitral (valve) prolapse	0.005	0.995	0.000
I42.6 Alcoholic cardiomyopathy	0.005	0.995	0.000
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
H34.8 Other retinal vascular occlusions	0.005	0.995	0.000
I45 Other conduction disorders	0.005	0.995	0.000
Y52.1 Calcium-channel blockers	0.004	0.995	0.000
I42.0 Dilated cardiomyopathy	0.005	0.995	0.000
I34.0 Mitral (valve) insufficiency	0.005	0.995	0.000
I45.5 Other specified heart block	0.004	0.995	0.000
I42.8 Other cardiomyopathies	0.004	0.996	0.000
I36 Nonrheumatic tricuspid valve disorders	0.004	0.996	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.004	0.996	0.000
I42.5 Other restrictive cardiomyopathy	0.004	0.996	0.000
I42.4 Endocardial fibroelastosis	0.004	0.996	0.000
I42.3 Endomyocardial (eosinophilic) disease	0.004	0.996	0.000
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.004	0.996	0.000
I45.3 Trifascicular block	0.004	0.996	0.000
I46 Cardiac arrest	0.004	0.996	0.000
H34.1 Central retinal artery occlusion	0.004	0.996	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.004	0.996	0.000
I37 Pulmonary valve disorders	0.004	0.996	0.000
I45.4 Nonspecific intraventricular block	0.004	0.996	0.000
Y45.1 Salicylates	0.004	0.996	0.000
I46.9 Cardiac arrest, unspecified	0.004	0.996	0.000
I40 Acute myocarditis	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.004	0.996	0.000
I45.1 Other and unspecified right bundle-branch block	0.004	0.996	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
I42.2 Other hypertrophic cardiomyopathy	0.004	0.996	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.004	0.996	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.996	0.004
N73.4 Female chronic pelvic peritonitis	0.000	0.996	0.004
N73.3 Female acute pelvic peritonitis	0.000	0.996	0.004
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.996	0.004
H34 Retinal vascular occlusions	0.004	0.996	0.000
J86.9 Pyothorax without fistula	0.000	0.996	0.004
Y60.9 During unspecified surgical and medical care	0.000	0.996	0.004
Y60.7 During administration of enema	0.000	0.996	0.004
Y60.6 During aspiration, puncture and other catheterisation	0.000	0.996	0.004
Y60.3 During injection or immunisation	0.000	0.996	0.004
Y60.2 During kidney dialysis or other perfusion	0.000	0.996	0.004
Y60.1 During infusion or transfusion	0.000	0.996	0.004
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Y60.8 During other surgical and medical care	0.000	0.996	0.004
I52 Other heart disorders in diseases classified elsewhere	0.004	0.996	0.000
I48 Atrial fibrillation and flutter	0.004	0.996	0.000
I43 Cardiomyopathy in diseases classified elsewhere	0.004	0.996	0.000
I41 Myocarditis in diseases classified elsewhere	0.004	0.996	0.000
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.004	0.996	0.000
I32 Pericarditis in diseases classified elsewhere	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
N73.5 Female pelvic peritonitis, unspecified	0.000	0.996	0.004
I34.8 Other nonrheumatic mitral valve disorders	0.004	0.996	0.000
Y60.4 During endoscopic examination	0.000	0.996	0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
Y52.7 Peripheral vasodilators	0.004	0.996	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
I30 Acute pericarditis	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.996	0.004
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.996	0.004
Y60.5 During heart catheterisation	0.000	0.996	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
I45.0 Right fascicular block	0.003	0.996	0.000
J86.0 Pyothorax with fistula	0.000	0.996	0.004
Y46.4 Iminostilbenes	0.004	0.996	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.996	0.003
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
I37.1 Pulmonary valve insufficiency	0.003	0.996	0.000
I45.9 Conduction disorder, unspecified	0.003	0.996	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.003	0.997	0.000
I36.9 Nonrheumatic tricuspid valve disorder, unspecified	0.003	0.997	0.000
I36.8 Other nonrheumatic tricuspid valve disorders	0.003	0.997	0.000
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency	0.003	0.997	0.000
I36.0 Nonrheumatic tricuspid (valve) stenosis	0.003	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
I40.0 Infective myocarditis	0.003	0.997	0.000
J86 Pyothorax	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
H34.2 Other retinal artery occlusions	0.003	0.997	0.000
I46.1 Sudden cardiac death, so described	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.997	0.003
N80.3 Endometriosis of pelvic peritoneum	0.000	0.997	0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.003	0.997	0.000
H53.2 Diplopia	0.000	0.997	0.003
I37.9 Pulmonary valve disorder, unspecified	0.003	0.997	0.000
I37.8 Other pulmonary valve disorders	0.003	0.997	0.000
I37.2 Pulmonary valve stenosis with insufficiency	0.003	0.997	0.000
I37.0 Pulmonary valve stenosis	0.003	0.997	0.000
W02.9 Unspecified place	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
H34.9 Retinal vascular occlusion, unspecified	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
I40.9 Acute myocarditis, unspecified	0.003	0.997	0.000
I40.8 Other acute myocarditis	0.003	0.997	0.000
I40.1 Isolated myocarditis	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
D50 Iron deficiency anaemia	0.000	0.997	0.003
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
H34.0 Transient retinal artery occlusion	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
I45.8 Other specified conduction disorders	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
I30.9 Acute pericarditis, unspecified	0.003	0.997	0.000
W19.9 Unspecified place	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
I32.8 Pericarditis in other diseases classified elsewhere	0.003	0.997	0.000
I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
I32.0 Pericarditis in bacterial diseases classified elsewhere	0.003	0.997	0.000
I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere	0.003	0.997	0.000
I39.4 Multiple valve disorders in diseases classified elsewhere	0.003	0.997	0.000
I39.3 Pulmonary valve disorders in diseases classified elsewhere	0.003	0.997	0.000
I39.2 Tricuspid valve disorders in diseases classified elsewhere	0.003	0.997	0.000
I39.1 Aortic valve disorders in diseases classified elsewhere	0.003	0.997	0.000
I39.0 Mitral valve disorders in diseases classified elsewhere	0.003	0.997	0.000
I41.8 Myocarditis in other diseases classified elsewhere	0.003	0.997	0.000
I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
I41.1 Myocarditis in viral diseases classified elsewhere	0.003	0.997	0.000
I41.0 Myocarditis in bacterial diseases classified elsewhere	0.003	0.997	0.000
I43.8 Cardiomyopathy in other diseases classified elsewhere	0.003	0.997	0.000
I43.2 Cardiomyopathy in nutritional diseases	0.003	0.997	0.000
I43.1 Cardiomyopathy in metabolic diseases	0.003	0.997	0.000
I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
I48.9 Atrial fibrillation and atrial flutter, unspecified	0.003	0.997	0.000
I48.4 Atypical atrial flutter	0.003	0.997	0.000
I48.3 Typical atrial flutter	0.003	0.997	0.000
I48.2 Chronic atrial fibrillation	0.003	0.997	0.000
I48.1 Persistent atrial fibrillation	0.003	0.997	0.000
I48.0 Paroxysmal atrial fibrillation	0.003	0.997	0.000
I52.8 Other heart disorders in other diseases classified elsewhere	0.003	0.997	0.000
I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
I52.0 Other heart disorders in bacterial diseases classified elsewhere	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.997	0.003
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.003	0.997	0.000
I30.8 Other forms of acute pericarditis	0.003	0.997	0.000
I30.0 Acute nonspecific idiopathic pericarditis	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.997	0.003
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.003	0.997	0.000
I46.0 Cardiac arrest with successful resuscitation	0.003	0.997	0.000
K91.3 Postoperative intestinal obstruction	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
I33 Acute and subacute endocarditis	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
K82.8 Other specified diseases of gallbladder	0.000	0.997	0.003
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.003	0.997	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.997	0.003
I47 Paroxysmal tachycardia	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
I30.1 Infective pericarditis	0.003	0.997	0.000
K25.4 Chronic or unspecified with haemorrhage	0.003	0.997	0.000
K91.1 Postgastric surgery syndromes	0.000	0.997	0.003
Y41.0 Sulphonamides	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
I49.1 Atrial premature depolarisation	0.003	0.997	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.997	0.003
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.003	0.997	0.000
I49 Other cardiac arrhythmias	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.002	0.997	0.000
K91.5 Postcholecystectomy syndrome	0.000	0.997	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
I38 Endocarditis, valve unspecified	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.997	0.000
Y50.8 Other central nervous system stimulants	0.002	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.997	0.000
Y50.1 Opioid receptor antagonists	0.002	0.997	0.000
Y50.0 Analeptics	0.002	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
Y55.5 Anticommon cold drugs	0.002	0.997	0.000
Y55.4 Expectorants	0.002	0.997	0.000
Y55.3 Antitussives	0.002	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
Y55.0 Oxytocic drugs	0.002	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.997	0.000
Y58.5 Diphtheria vaccine	0.002	0.997	0.000
Y58.4 Tetanus vaccine	0.002	0.997	0.000
Y58.3 Plague vaccine	0.002	0.997	0.000
Y58.2 Cholera vaccine	0.002	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.000	0.997	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.997	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
D50.1 Sideropenic dysphagia	0.000	0.997	0.002
N80.1 Endometriosis of ovary	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.997	0.000
Y59.2 Protozoal vaccines	0.002	0.997	0.000
Y59.1 Rickettsial vaccines	0.002	0.997	0.000
Y59.0 Viral vaccines	0.002	0.997	0.000
I51 Complications and ill-defined descriptions of heart disease	0.003	0.997	0.000
N17.9 Acute renal failure, unspecified	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
I45.2 Bifascicular block	0.002	0.998	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.998	0.002
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
I45.6 Preexcitation syndrome	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
W00-W19 Falls	0.002	0.998	0.000
I33.9 Acute endocarditis, unspecified	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
W07 Fall involving chair	0.002	0.998	0.000
W05.0 Home	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.998	0.002
S06.3 Focal brain injury	0.002	0.998	0.000
W05 Fall involving wheelchair	0.002	0.998	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.002	0.998	0.000
I47.0 Reentry ventricular arrhythmia	0.002	0.998	0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified	0.002	0.998	0.000
W07.0 Home	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.998	0.002
W02.8 Other specified place	0.002	0.998	0.000
W02.3 Sports and athletics area	0.002	0.998	0.000
W02.7 Farm	0.002	0.998	0.000
W02.6 Industrial and construction area	0.002	0.998	0.000
W02.5 Trade and service area	0.002	0.998	0.000
W02.4 Street and highway	0.002	0.998	0.000
W02.2 School, other institution and public administrative area	0.002	0.998	0.000
W02.1 Residential institution	0.002	0.998	0.000
W02.0 Home	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
I51.4 Myocarditis, unspecified	0.002	0.998	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.002	0.998	0.000
I49.2 Junctional premature depolarisation	0.002	0.998	0.000
I51.3 Intracardiac thrombosis, not elsewhere classified	0.002	0.998	0.000
Z57.3 Occupational exposure to other air contaminants	0.002	0.998	0.000
W17 Other fall from one level to another	0.002	0.998	0.000
W15 Fall from cliff	0.002	0.998	0.000
W00 Fall on same level involving ice and snow	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
W01.1 Residential institution	0.002	0.998	0.000
I51.9 Heart disease, unspecified	0.002	0.998	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.002	0.998	0.000
Y64 Contaminated medical or biological substances	0.000	0.998	0.002
Y63 Failure in dosage during surgical and medical care	0.000	0.998	0.002
Y62 Failure of sterile precautions during surgical and medical care	0.000	0.998	0.002
Y61 Foreign object accidentally left in body during surgical and medical care	0.000	0.998	0.002
Y69 Unspecified misadventure during surgical and medical care	0.000	0.998	0.002
Y66 Nonadministration of surgical and medical care	0.000	0.998	0.002
I49.5 Sick sinus syndrome	0.002	0.998	0.000
Y86 Sequelae of other accidents	0.000	0.998	0.002
D86.9 Sarcoidosis, unspecified	0.002	0.998	0.000
I51.5 Myocardial degeneration	0.002	0.998	0.000
I51.2 Rupture of papillary muscle, not elsewhere classified	0.002	0.998	0.000
K04.8 Radicular cyst	0.002	0.998	0.000
W01.4 Street and highway	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
W10 Fall on and from stairs and steps	0.002	0.998	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.002	0.998	0.000
K83.0 Cholangitis	0.000	0.998	0.002
W10.3 Sports and athletics area	0.002	0.998	0.000
W13 Fall from, out of or through building or structure	0.002	0.998	0.000
Y65 Other misadventures during surgical and medical care	0.000	0.998	0.002
W00.3 Sports and athletics area	0.002	0.998	0.000
I49.0 Ventricular fibrillation and flutter	0.002	0.998	0.000
W07.9 Unspecified place	0.002	0.998	0.000
W15.8 Other specified place	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
D51 Vitamin B12 deficiency anaemia	0.002	0.998	0.000
W17.3 Sports and athletics area	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.001
Z98.0 Intestinal bypass and anastomosis status	0.000	0.998	0.002
W16 Diving or jumping into water causing injury other than drowning or submersion	0.002	0.998	0.000
W12 Fall on and from scaffolding	0.002	0.998	0.000
W11 Fall on and from ladder	0.002	0.998	0.000
W09 Fall involving playground equipment	0.002	0.998	0.000
W04 Fall while being carried or supported by other persons	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.002	0.998	0.000
W07.2 School, other institution and public administrative area	0.002	0.998	0.000
W07.8 Other specified place	0.002	0.998	0.000
W07.7 Farm	0.002	0.998	0.000
W07.6 Industrial and construction area	0.002	0.998	0.000
W07.5 Trade and service area	0.002	0.998	0.000
W07.4 Street and highway	0.002	0.998	0.000
W07.3 Sports and athletics area	0.002	0.998	0.000
W07.1 Residential institution	0.002	0.998	0.000
W17.5 Trade and service area	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
W06 Fall involving bed	0.002	0.998	0.000
S06.31 Focal brain injury (with open intracranial wound)	0.002	0.998	0.000
D52.9 Folate deficiency anaemia, unspecified	0.002	0.998	0.000
W05.9 Unspecified place	0.002	0.998	0.000
W05.8 Other specified place	0.002	0.998	0.000
W05.7 Farm	0.002	0.998	0.000
W05.6 Industrial and construction area	0.002	0.998	0.000
W05.5 Trade and service area	0.002	0.998	0.000
W05.4 Street and highway	0.002	0.998	0.000
W05.3 Sports and athletics area	0.002	0.998	0.000
W05.2 School, other institution and public administrative area	0.002	0.998	0.000
W05.1 Residential institution	0.002	0.998	0.000
W10.4 Street and highway	0.002	0.998	0.000
J45.0 Predominantly allergic asthma	0.000	0.998	0.002
W01.9 Unspecified place	0.002	0.998	0.000
W01.8 Other specified place	0.002	0.998	0.000
W01.5 Trade and service area	0.002	0.998	0.000
W01.3 Sports and athletics area	0.002	0.998	0.000
W01.2 School, other institution and public administrative area	0.002	0.998	0.000
W01.0 Home	0.002	0.998	0.000
W01.7 Farm	0.002	0.998	0.000
W01.6 Industrial and construction area	0.002	0.998	0.000
W17.2 School, other institution and public administrative area	0.002	0.998	0.000
W01.49 Fall on same level from slipping, tripping and stumbling; Street and highway; During unspecified activity	0.002	0.998	0.000
I44.1 Atrioventricular block, second degree	0.002	0.998	0.000
I47.2 Ventricular tachycardia	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
I44 Atrioventricular and left bundle-branch block	0.002	0.998	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.000	0.998	0.002
S06.20 Diffuse brain injury (without open intracranial wound)	0.002	0.998	0.000
W02.31 Fall involving ice-skates, skis, roller-skates or skateboards; Sports and athletics area; While engaged in leisure activity	0.002	0.998	0.000
W02.30 Fall involving ice-skates, skis, roller-skates or skateboards; Sports and athletics area; While engaged in sports activity	0.002	0.998	0.000
W02.81 Fall involving ice-skates, skis, roller-skates or skateboards; Other specified places; While engaged in leisure activity	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
J85 Abscess of lung and mediastinum	0.000	0.998	0.002
G12.2 Motor neuron disease	0.000	0.998	0.002
I49.8 Other specified cardiac arrhythmias	0.002	0.998	0.000
W17.6 Industrial and construction area	0.002	0.998	0.000
L85.8 Other specified epidermal thickening	0.002	0.998	0.000
W19 Unspecified fall	0.002	0.998	0.000
W14 Fall from tree	0.002	0.998	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.002	0.998	0.000
W00.9 Unspecified place	0.002	0.998	0.000
W00.8 Other specified place	0.002	0.998	0.000
W00.4 Street and highway	0.002	0.998	0.000
W00.0 Home	0.002	0.998	0.000
W00.7 Farm	0.002	0.998	0.000
W00.6 Industrial and construction area	0.002	0.998	0.000
W00.5 Trade and service area	0.002	0.998	0.000
W00.2 School, other institution and public administrative area	0.002	0.998	0.000
W00.1 Residential institution	0.002	0.998	0.000
W17.9 Unspecified place	0.002	0.998	0.000
W17.8 Other specified place	0.002	0.998	0.000
W17.0 Home	0.002	0.998	0.000
W17.7 Farm	0.002	0.998	0.000
W17.1 Residential institution	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.002	0.998	0.000
J85.2 Abscess of lung without pneumonia	0.000	0.998	0.002
S06.2 Diffuse brain injury	0.002	0.998	0.000
W15.9 Unspecified place	0.002	0.998	0.000
W15.7 Farm	0.002	0.998	0.000
W15.6 Industrial and construction area	0.002	0.998	0.000
W15.5 Trade and service area	0.002	0.998	0.000
W15.4 Street and highway	0.002	0.998	0.000
W15.3 Sports and athletics area	0.002	0.998	0.000
W15.2 School, other institution and public administrative area	0.002	0.998	0.000
W15.1 Residential institution	0.002	0.998	0.000
W15.0 Home	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
I51.6 Cardiovascular disease, unspecified	0.002	0.998	0.000
O26.8 Other specified pregnancy-related conditions	0.002	0.998	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.000	0.998	0.002
Z71.1 Person with feared complaint in whom no diagnosis is made	0.000	0.998	0.002
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.002	0.998	0.000
W13.9 Unspecified place	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.000
Y61.9 During unspecified surgical and medical care	0.000	0.998	0.001
Y61.8 During other surgical and medical care	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations